Axmed

We believe access to medicines should be equal for all. We bring an innovative marketplace to empower emerging markets to access medicines more competitively.

Imagine a world where critical medicines are within reach, affordable, and synonymous with quality, no matter where you are. That's the world we're building with our unique, demand-aggregation model that unites healthcare providers across LMICs. At the heart of our identity is a resolute commitment: to build a future where geography and income never stand between any individual and life-saving medicines. Our platform isn't merely a space for transactions, we unlock affordable access to medicines by aggregating demand across healthcare providers. We also help manufacturers build a sustainable and reliable global access strategy. Our business focuses on LMICs and strengthens the purchasing power of these markets to ensure the supply of cost-effective, high-quality medicines. We partner exclusively with authorized, high-quality pharmaceutical companies and certified caregivers to accelerate access to medicines.

02/26/2026

In Sub-Saharan Africa, postpartum haemorrhage (PPH) remains the leading cause of maternal death. In far too many delivery rooms, health workers still rely on visual estimates of blood loss - a method that leaves critical decisions up to chance when every second counts.

The calibrated obstetric drape changes that. This simple but powerful innovation, the drape provides an immediate, accurate measurement of blood loss - helping providers to detect PPH early and respond with speed and certainty.

Through our partnership with Sinapi Biomedical, we are delivering 600,000 drapes to an East African government, supporting a nationwide shift in how PPH is diagnosed and managed. 

Together, Sinapi and Axmed are making it possible for tools like this to reach the facilities that need them most. Because quality care shouldn’t depend on geography.

We’re just getting started.

02/24/2026

One week on.

The news of our $6M grant funding from the Gates Foundation to expand access to affordable, high-quality medicines across more markets and therapeutic areas has sparked global conversation and real momentum.

In just seven days, our announcement has been featured in 570+ media outlets, reaching a potential audience of 72 million across global health, finance, and innovation communities.

From the importance of localized procurement models to the future of global supply chain infrastructure, the coverage reflects what this moment represents: growing recognition that building better systems for medicine access is not only possible, it is urgent.

📰 Swipe to see some of the coverage highlights

🔗 Read the full release at the link in our bio.

02/19/2026

What happens when AI stops being a side tool and starts shaping how product teams actually plan, think, and build?

In this month’s Tech Blog, Anaman, Senior Product Manager, and Albergante, CTO at Axmed, explore how agent-driven workflows are changing the way we approach product planning - moving beyond static roadmaps and into a more contextual, collaborative way of working.

It’s an evolution that is taking teams from simply copy/pasting into chatbots to AI agents embedded in real workflows, connecting directly to internal codebases and Jira tickets.

The result is stronger planning, faster ex*****on, and decisions grounded in real system context. 🧠

Read now at the link in our bio.

02/17/2026

We’re proud to announce that Axmed has secured $6 million in non-dilutive grant funding from the Gates Foundation to scale our global infrastructure for medicine access.

The grant builds on the Foundation’s prior $5 million support and reflects continued conviction in Axmed’s ex*****on and operating model. With additional backing from Founderful Ventures, the company has now raised a total of $𝟏𝟑 𝐦𝐢𝐥𝐥𝐢𝐨𝐧 in capital to date.

Since launch, we’ve built the world’s first geo-agnostic pooled procurement and integrated logistics platform purpose-built for low-and middle-income countries (LMICs). In just the last year, the Axmed platform:

🔹 Delivered 1,800+ metric tons of medicines and health supplies
🔹 Reached over 4.2 million people, up from 750,000 in 2024
🔹 Achieved 12x growth in annualized revenue year-on-year
🔹 Enabled average cost savings of 30–35% through demand aggregation and price transparency
🔹 Achieved a 70% repeat purchase rate, underscoring strong product-market fit and sustained buyer trust

The new funding will accelerate Axmed’s expansion across Africa and support procurement programs spanning multiple therapeutic areas, including family planning and malaria products serving mothers, children, and underserved patient populations across LMICs over the next 12 to 18 months.

Our ambition: reach 20+ countries by the end of 2026, serve 50+ million people within three years, and 100+ million by year five.

At its core, this is about more than growth. It’s about disciplined ex*****on at scale, strengthening the procurement systems and infrastructure that health systems need to deliver high-quality, affordable medicines to the people who need them most.

To the Gates Foundation, thank you for your continued partnership. To all those working to close the access gap: we’re with you.

📣 Read the full release at the link in our bio.

01/27/2026

Access to Medicines Will Be Won or Lost on How Markets Are Built

There is a persistent misconception in global health: that expanding access to medicines requires sacrificing commercial viability. That impact and returns sit in opposition to one another.

This framing is outdated, and it continues to slow real progress at the moment it is most needed.

Low- and middle-income countries (LMICs) account for over 85% of the world’s population and nearly 90% of the global disease burden, yet they represent less than 6% of global pharmaceutical revenue.

This imbalance is not a mystery. It is the logical outcome of markets designed without LMICs in mind. It is the architecture of the market itself.

Read more from our Co-Founder and Chief Commercial Officer Felix Ohnmacht in his latest article, Access to Medicines Will Be Won or Lost on How Markets Are Built, which argues that the future of access will be shaped by business models that treat LMICs as essential markets, and embed efficiency, transparency, and sustainability into how they function.

👉 Read the full piece: https://lnkd.in/eYNjpNiA

01/23/2026

If we want resilient health systems, procurement can no longer remain invisible.

Mattia Albergante, CTO at Axmed, argues that while conversations around AI advancement tend to focus on diagnostics and drug discovery, procurement is an often-overlooked area in keen need of an innovation overhaul.

Fragmentation and manual processes in procurement are quietly undermining impact, with thousands of procurement units, hospitals, and pharmacies continuing to operate in isolation.

AI, he argues, provides a real opportunity to make an impact.

👉 Read the full piece here: https://medium.com//procurement-as-the-invisible-bottleneck-in-global-health-deba5b92b4cb

01/21/2026

How are global health policymakers realigning their priorities in a post-USAID world?

Most conversations about the post-USAID global health landscape are still circling the same questions: where will the money come from, and how do we make it stretch further?

That focus is necessary, but insufficient.

Axmed’s conversations with policymakers in the markets we work in point to a shift in approach. Leaders are becoming less focused on short-term savings and more focused on how to mobilize domestic capacity to meet their country’s health needs both now and in the future.

This includes diversifying procurement systems. Because frankly, current procurement models are not fit for a world of volatility. Even with diversified global health funding, systems built around a single way of buying, supplying and distributing medicines will continue to fail under pressure.

Read more from our Co-founder and Chief Operating Officer Sofía Radley-Searle (M. Pharm, MBA) in her latest article, Future-Proofing Health Procurement in a Post-USAID World, which argues that procurement must be re-positioned as strategic infrastructure, not an administrative or cost-containment function.

👉 Read the full piece here: https://lnkd.in/eea_5UFv

01/13/2026

In this new episode of the Every Pregnancy podcast Born Into, our CEO Emmanuel Akpakwu reflects on the early days of Axmed and what the response to the platform revealed about the deep frustration and unmet need within global health systems for something more sustainable.

Emmanuel discusses how addressing critical gaps in healthcare access and improving the patient journey are essential to our mission. He shares how costs prevent patients from ever reaching care, and why our responsibility extends beyond medicines to building a stronger, more equitable healthcare ecosystem.

"If we exist to improve access to medicines for mothers, newborns, and patients across the disease spectrum, we have to make that journey more seamless. We have a responsibility to the ecosystem, not just to generate sustainable outcomes from it, but to give back and contribute to a virtuous cycle that supports it."

🎧 Listen now to hear more about our vision for transforming healthcare access and building a more equitable, sustainable ecosystem that serves everyone. Available wherever you get your podcasts, or via Every Pregnancy’s link in bio.

12/23/2025

As 2025 draws to a close, we want to thank every Axmed partner, team member, supplier, and health system leader who made this year possible.

Every order fulfilled. Every shipment delivered. Every product reaching the frontline: none of it happens without shared purpose and collaboration.

Together, we’ve expanded access to essential medicines, opened new markets, strengthened procurement systems, and continued to push for a more transparent, equitable model of health supply.

There’s still much to do. But for now, we pause in gratitude.

Wishing you a restful break, a healthy holiday season, and strength for the journey ahead. See you in 2026.

12/19/2025

From fragmented feedback to real-time insights: building better tools for better decisions.

What do you do when your startup grows faster than your feedback systems can keep up?

In this month’s Tech Blog, Derrick Tsorme, Product Designer at Axmed, takes us behind the scenes of how a scrappy experiment evolved into a fully automated AI-powered pipeline, built using Microsoft Teams, Slack, n8n, and a lot of curiosity.

💬 The problem: scattered user feedback across calls, emails, and chats
⚙️ The fix: a seamless feedback-to-insight system that lives where our teams already work
📊 The result: cleaner data, clearer priorities, faster product improvements

This isn’t just a story about tools. It’s about making sure that every user voice, every frontline pain point, and every promising idea makes it to the people who can act on it, without weeks of delays or spreadsheets lost in inboxes.

Read the full breakdown and what’s next for the platform here: https://medium.com//a-teams-bot-a-slack-bot-n8n-and-the-end-of-fragmented-feedback-3537052e5637.

12/18/2025

Axmed and LifeNet International Announce Transformative Partnership to Expand Access to Essential Maternal and Newborn Health Products

Postpartum haemorrhage (PPH), is the leading cause of maternal death in Sub-Saharan Africa. The E-MOTIVE study demonstrated that early detection of PPH using a calibrated obstetric drape combined with a bundle of first-response treatments reduced severe PPH and maternal death from bleeding by 60%.

Today we’re proud to announce a new partnership with LifeNet International, that is bringing these breakthrough findings to the frontlines, equipping health facilities across some of Africa's most under-resourced communities with calibrated drapes, treatment training, heat-stable carbetocin and other critical supplies that enable safe deliveries.

Through this collaboration, heat-stable carbetocin and other critical MNCH products are now reaching frontline facilities like the Presbyterian Health Centre in Fooshegu, Ghana, where more than 120 mothers deliver each month and where zero maternal deaths have been reported in recent months. A testament to the work LifeNet and Axmed are doing to drastically improve the chance for a healthy start to life for delivering mothers and babies throughout Ghana.

This is just the start. By combining LifeNet’s capacity-building expertise with the reach of the Axmed platform, we are building a model for lasting, scalable access. Every mother deserves the chance to deliver safely. Every newborn deserves a healthy start.

Read the full release on PR Newswire here: https://www.prnewswire.com/news-releases/axmed-and-lifenet-international-announce-transformative-partnership-to-expand-access-to-essential-maternal-and-newborn-health-products-302645064.html?tc=eml_cleartime

12/17/2025

Scaling access through state partnerships

At a recent roundtable in Kano, 11 State Drug Management Agencies (DMAs) joined the Axmed team for a focused session on strengthening public procurement systems for maternal, newborn, and child health (MNCH) commodities.

🎥 In this video, hear from Aisha Isyaku (Executive Secretary, KADHSMA), Gali Sule (Director General, DMCSA Kano), and Mohammed Ndagi Usman (Director of Procurement, NSDHCMA) as they share firsthand reflections on how partnering with Axmed is helping them improve access and efficiency across their systems.

At the heart of the roundtable discussion was the MNCH Matching Fund, a co-financing mechanism supported by the Gates Foundation. The model enables states to double the impact of their health budgets by matching their procurement of essential commodities through the Axmed platform.

Participants highlighted several opportunities the fund offers:

✅ The potential to realize cost savings and achieve faster, more transparent deliveries
✅ Growing interest from states planning their first deliveries
✅ Broad support for the model as a sustainable approach to improving access

By listening to the priorities of public sector partners and responding with practical tools and support, we can help build a future where access to essential medicines is faster, fairer, and more reliable for everyone.

We welcome enquiries from other Nigerian state governments and public health agencies across Sub-Saharan Africa interested in exploring how this model could be applied in their context. Reach out to our team to learn more.

Address

Boston, MA

Website

https://www.axmed.com/

Alerts

Be the first to know and let us send you an email when Axmed posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Want your practice to be the top-listed Clinic in Boston?